Lactate dehydrogenase (LDH) as an indicator of pre-eclampsia.

IF 1.9
Bioinformation Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI:10.6026/973206300210116
Kapil Raghuwanshi, Bhupesh Kushram, Dileep Dandotiya, Sudhakar Petkar, Swapnali Tambade, Mahendra Gandhe
{"title":"Lactate dehydrogenase (LDH) as an indicator of pre-eclampsia.","authors":"Kapil Raghuwanshi, Bhupesh Kushram, Dileep Dandotiya, Sudhakar Petkar, Swapnali Tambade, Mahendra Gandhe","doi":"10.6026/973206300210116","DOIUrl":null,"url":null,"abstract":"<p><p>High blood pressure (higher than 140/90 mm Hg), proteinuria and swelling due to fluid retention are symptoms of preeclampsia, a disease that affects pregnant women after the 20th week of pregnancy. The cytoplasm of cells undergoing anaerobic glycolysis contains the enzyme lactate dehydrogenase or LDH. Therefore, it is of interest to ascertain the blood lactate dehydrogenase levels of pre-eclamptic women, to assess and analyze these levels, to compare lactate dehydrogenase levels in different groups of preeclampsia patients and healthy controls and to examine the role of lactate dehydrogenase in preeclampsia severity ratings. Increased blood lactate dehydrogenase levels are associated with more severe preeclampsia, according to this study's results. Thus, it is crucial to determine lactate dehydrogenase levels in pre-eclamptic women early on so that these patients may get the right medicine and reduce the morbidity and mortality associated with these disorders.</p>","PeriodicalId":8962,"journal":{"name":"Bioinformation","volume":"21 2","pages":"116-120"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044190/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6026/973206300210116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

High blood pressure (higher than 140/90 mm Hg), proteinuria and swelling due to fluid retention are symptoms of preeclampsia, a disease that affects pregnant women after the 20th week of pregnancy. The cytoplasm of cells undergoing anaerobic glycolysis contains the enzyme lactate dehydrogenase or LDH. Therefore, it is of interest to ascertain the blood lactate dehydrogenase levels of pre-eclamptic women, to assess and analyze these levels, to compare lactate dehydrogenase levels in different groups of preeclampsia patients and healthy controls and to examine the role of lactate dehydrogenase in preeclampsia severity ratings. Increased blood lactate dehydrogenase levels are associated with more severe preeclampsia, according to this study's results. Thus, it is crucial to determine lactate dehydrogenase levels in pre-eclamptic women early on so that these patients may get the right medicine and reduce the morbidity and mortality associated with these disorders.

乳酸脱氢酶(LDH)作为先兆子痫的指标。
高血压(高于140/90毫米汞柱)、蛋白尿和液体潴留引起的肿胀是先兆子痫的症状,这是一种影响怀孕20周后孕妇的疾病。进行厌氧糖酵解的细胞的细胞质含有乳酸脱氢酶或LDH。因此,确定子痫前期妇女血乳酸脱氢酶水平,评估和分析这些水平,比较不同组子痫前期患者和健康对照的乳酸脱氢酶水平,并检查乳酸脱氢酶在子痫前期严重程度评分中的作用是有意义的。根据这项研究的结果,血乳酸脱氢酶水平升高与更严重的先兆子痫有关。因此,早期确定子痫前期妇女的乳酸脱氢酶水平是至关重要的,这样这些患者就可以得到正确的药物,降低与这些疾病相关的发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioinformation
Bioinformation MATHEMATICAL & COMPUTATIONAL BIOLOGY-
自引率
0.00%
发文量
128
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信